Sanigen Co. Ltd (KOSDAQ:188260)
2,070.00
+45.00 (2.22%)
At close: Sep 3, 2026
Sanigen Co. Revenue
Sanigen Co. had revenue of 3.81B KRW in the quarter ending June 30, 2026, a decrease of -5.83%. This brings the company's revenue in the last twelve months to 14.21B, up 7.03% year-over-year. In the year 2025, Sanigen Co. had annual revenue of 15.35B, down -0.48%.
Revenue (ttm)
14.21B
Revenue Growth
+7.03%
P/S Ratio
1.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.35B | -73.62M | -0.48% |
| Dec 31, 2024 | 15.43B | -4.76B | -23.57% |
| Dec 31, 2023 | 20.19B | -6.57B | -24.56% |
| Dec 31, 2022 | 26.76B | 1.54B | 6.09% |
| Dec 31, 2021 | 25.22B | 1.73B | 7.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 116.56B |
| DENTIS CO.,Ltd | 111.69B |
| Corentec | 104.75B |
| M.I.TECH Co.,Ltd | 70.72B |
| Bio Protech | 20.58B |
| Alpha AI | 14.56B |
| Finemedix | 11.43B |
| Genolution | 10.03B |